Minocycline vs Placebo for Patients With Mild Alzheimer Disease

This randomized clinical trial examines whether 24 months of minocycline treatment can modify cognitive and functional decline in patients with mild Alzheimer disease.

https://jamanetwork.com/journals/jamaneurology/fullarticle/2755279

Source: JAMA Neurology - November 18, 2019 Category: Neurology Source Type: research